Oncimmune Holdings plc (AIM:ONC)
London
· Delayed Price · Currency is GBP · Price in GBX 1.140
-0.050 (-4.20%)
Inactive · Last trade price
on Mar 14, 2025
Oncimmune Holdings Income Statement
Financials in millions GBP. Fiscal year is September - August.
Millions GBP. Fiscal year is Sep - Aug.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
| Revenue | 2.74 | 1.15 | 1.85 | 3.21 | 3.72 | Upgrade
|
| Revenue Growth (YoY) | 137.76% | -37.82% | -42.21% | -13.86% | 631.24% | Upgrade
|
| Cost of Revenue | 1.51 | 0.36 | 0.9 | 1.75 | 0.87 | Upgrade
|
| Gross Profit | 1.23 | 0.79 | 0.96 | 1.46 | 2.86 | Upgrade
|
| Selling, General & Admin | 4.46 | 3.78 | 5.2 | 7.05 | 6.7 | Upgrade
|
| Research & Development | - | 1.26 | 0.79 | 1.52 | 1.62 | Upgrade
|
| Other Operating Expenses | - | -0.32 | - | -0.33 | -0.24 | Upgrade
|
| Operating Expenses | 4.46 | 4.72 | 5.99 | 10.04 | 8.07 | Upgrade
|
| Operating Income | -3.23 | -3.92 | -5.03 | -8.59 | -5.22 | Upgrade
|
| Interest Expense | -0.69 | -0.52 | -0.02 | -0.94 | -0.84 | Upgrade
|
| Interest & Investment Income | 0.02 | - | 0.01 | - | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.06 | -0.2 | - | - | 0.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -1.28 | -0.22 | - | -0.12 | Upgrade
|
| EBT Excluding Unusual Items | -3.98 | -5.93 | -5.27 | -9.53 | -5.77 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.03 | Upgrade
|
| Other Unusual Items | - | - | 0 | - | 0.04 | Upgrade
|
| Pretax Income | -3.98 | -5.93 | -5.26 | -9.53 | -5.7 | Upgrade
|
| Income Tax Expense | -0.48 | 0.22 | 0.21 | -0.02 | -1.07 | Upgrade
|
| Earnings From Continuing Operations | -3.5 | -6.15 | -5.47 | -9.51 | -4.63 | Upgrade
|
| Earnings From Discontinued Operations | -0.13 | 10.26 | -3.64 | - | - | Upgrade
|
| Net Income | -3.63 | 4.1 | -9.11 | -9.51 | -4.63 | Upgrade
|
| Net Income to Common | -3.63 | 4.1 | -9.11 | -9.51 | -4.63 | Upgrade
|
| Shares Outstanding (Basic) | 74 | 73 | 69 | 69 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 74 | 73 | 69 | 69 | 65 | Upgrade
|
| Shares Change (YoY) | 2.16% | 5.13% | -0.57% | 7.53% | 2.01% | Upgrade
|
| EPS (Basic) | -0.05 | 0.06 | -0.13 | -0.14 | -0.07 | Upgrade
|
| EPS (Diluted) | -0.05 | 0.06 | -0.13 | -0.14 | -0.07 | Upgrade
|
| Free Cash Flow | -3.39 | -6.82 | -5.74 | -6.72 | -4.97 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.09 | -0.08 | -0.10 | -0.08 | Upgrade
|
| Gross Margin | 44.94% | 68.75% | 51.68% | 45.45% | 76.76% | Upgrade
|
| Operating Margin | -117.78% | -340.63% | -271.72% | -267.81% | -140.17% | Upgrade
|
| Profit Margin | -132.46% | 356.25% | -491.62% | -296.69% | -124.34% | Upgrade
|
| Free Cash Flow Margin | -123.77% | -592.19% | -309.93% | -209.45% | -133.61% | Upgrade
|
| EBITDA | -3.13 | -2.94 | -3.72 | -7.16 | -5.03 | Upgrade
|
| EBITDA Margin | -114.31% | -255.47% | -200.78% | -223.24% | -135.14% | Upgrade
|
| D&A For EBITDA | 0.1 | 0.98 | 1.31 | 1.43 | 0.19 | Upgrade
|
| EBIT | -3.23 | -3.92 | -5.03 | -8.59 | -5.22 | Upgrade
|
| EBIT Margin | -117.78% | - | -271.72% | -267.81% | -140.17% | Upgrade
|
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.